AWM — Airway Medix SA Cashflow Statement
0.000.00%
- PLN16.58m
- PLN25.54m
- PLN0.01m
Annual cashflow statement for Airway Medix SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -1.2 | -1.99 | -9.37 | -37.4 | -3.28 |
Non-Cash Items | 3.53 | -0.116 | -12.7 | 34.6 | 7.95 |
Unusual Items | |||||
Purchased R&D | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 2.65 | -0.146 | 16.3 | 2.34 | -8.87 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 4.98 | -2.25 | -5.85 | -0.442 | -4.2 |
Capital Expenditures | -6.72 | -5.02 | 0 | -0.13 | 0 |
Purchase of Fixed Assets | |||||
Cash from Investing Activities | -6.72 | -5.02 | 0 | -0.13 | 0 |
Financing Cash Flow Items | -3.95 | — | — | — | 0.548 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 1.4 | 8.73 | 3.71 | 0.55 | 4.85 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.345 | 1.51 | -2.19 | -0.022 | 0.653 |